Insights: DrugPatentWatch - Find Your Next Blockbuster

This article was originally published by Hao Zhong, Ging Chan, Yuanjia Hu, Hao Hu and Defang Ouyang in Pharmaceutics 2018, 10(4), 263 under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract :…

The post A Comprehensive Map of FDA-Approved Pharmaceutical Products appeared first on DrugPatentWatch - Make Better Decisions.

This paper was originally published by Maxwell Robert Morgan, Owen Gwilym Roberts, and Aled Morgan Edwards in Wellcome Open Res 2018, 3:154 under a Creative Commons Attribution License Abstract M4K…

The post Ideation and implementation of an open science drug discovery business model – M4K Pharma appeared first on DrugPatentWatch - Make Better Decisions.

This is a guest post from Pepper Hamilton Partners John P. Isacson and N. Nicole Stakleff. John can be contacted at [email protected] and Nicole can be contacted at [email protected]. The Federal Circuit recently…

The post Obviousness-Type Double Patenting Just Became Less of a Problem for Innovators appeared first on DrugPatentWatch - Make Better Decisions.

This article was originally published by Arun Kumar, Sandeep Kumar, and Arun Nanda in Adv Pharm Bull. 2018 Aug; 8(3): 355–363 under a Creative Commons License. Abstract Pharmaceutical Co-crystals are not new,…

The post A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals appeared first on DrugPatentWatch - Make Better Decisions.

Annual Drug Patent Expirations for ACTONEL Actonel is a drug marketed by Apil and Warner Chilcott and is included in two NDAs. It is available from four suppliers. There are…

The post New patent expiration for APIL drug ACTONEL appeared first on DrugPatentWatch - Make Better Decisions.

Annual Drug Patent Expirations for OFORTA Oforta is a drug marketed by Sanofi Aventis Us and is included in one NDA. There are two patents protecting this drug. This drug…

The post New patent expiration for Sanofi Aventis drug OFORTA appeared first on DrugPatentWatch - Make Better Decisions.

This chart shows the generic firms that had the most successful drug patent challenges last year. Companies that successfully challenge patents on branded drugs are granted six months of generic…

The post Most drug patent challenges last year appeared first on DrugPatentWatch - Make Better Decisions.

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…

The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on DrugPatentWatch - Make Better Decisions.

Annual Drug Patent Expirations for MOZOBIL Mozobil is a drug marketed by Genzyme and is included in one NDA. It is available from one supplier. There are three patents protecting…

The post New patent expiration for Genzyme drug MOZOBIL appeared first on DrugPatentWatch - Make Better Decisions.

Annual Drug Patent Expirations for ACTONEL+WITH+CALCIUM+%28COPACKAGED%29 Actonel With Calcium (copackaged) is a drug marketed by Warner Chilcott and is included in one NDA. There are five patents protecting this drug.…

The post New patent expiration for Warner Chilcott drug ACTONEL WITH CALCIUM (COPACKAGED) appeared first on DrugPatentWatch - Make Better Decisions.